Next 10 |
home / stock / lgstu / lgstu news
Listing on Nasdaq is expected to provide Tevogen Bio Holdings Inc. increased access to capital to accelerate development of its genetically unmodified off-the-shelf T cell therapy products for large patient populations. WARREN, N.J., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holding...
New York, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (“Semper Paratus”) (Nasdaq: LGST, LGSTW, LGSTU), a publicly-traded special purpose acquisition company, announced today that its shareholders have approved the proposed business combination (the...
New York, NY, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (“Semper Paratus”) (Nasdaq: LGST, LGSTW), a publicly-traded special purpose acquisition company, today announced that it has filed a supplement (“Prospectus Supplement”) to its defin...
The pro forma equity value of the portion of the combined company attributable to Tevogen Bio Inc (“Tevogen Bio”) stockholders is an expected $1.2 billion. Tevogen Bio is an advanced-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T...
New York, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (Nasdaq: LGST, the “ Company ”) announced today that it received a letter from the Listing Qualifications Department of The Nasdaq Stock Market (“ Nasdaq ”) confirming...
New York, NY, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (Nasdaq: LGST) (“Semper Paratus”), a publicly traded special purpose acquisition company, today announced the filing of a registration statement on Form S-4 (the “Registration Statement...
Tevogen Bio Inc. (“Tevogen Bio”) is an advanced-stage specialty immunotherapy biotech pioneer developing off-the-shelf, genetically unmodified T cell therapeutics in virology, oncology, and neurology. Founded by a consortium of top-tier biopharma executives and renowned scientis...
Semper Paratus Acquisition Corporation Announces the Separate Trading of its Class A Ordinary Shares and Warrants PR Newswire NEW YORK , Dec. 30, 2021 /PRNewswire/ -- Semper Paratus Acquisition Corporation (Nasdaq: LGSTU) (the "Company") announced today ...
Semper Paratus Acquisition Corporation Announces Closing of $345 Million Initial Public Offering PR Newswire NEW YORK , Nov. 8, 2021 /PRNewswire/ -- Semper Paratus Acquisition Corporation (the "Company") announced today the closing of its initial public offe...
November kicked off with a 12 IPO week and shoe brand Allbirds was at the front of the flock, posting a first-day pop of 93%. 23 SPACs went public this past week led by Trine II Acquisition, which raised $360 million to target the TMT industry. Two issuers postponed this past week...
News, Short Squeeze, Breakout and More Instantly...
Semper Paratus Acquisition Corporation Unit Company Name:
LGSTU Stock Symbol:
NASDAQ Market:
Semper Paratus Acquisition Corporation Unit Website:
Listing on Nasdaq is expected to provide Tevogen Bio Holdings Inc. increased access to capital to accelerate development of its genetically unmodified off-the-shelf T cell therapy products for large patient populations. WARREN, N.J., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio Holding...
New York, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (“Semper Paratus”) (Nasdaq: LGST, LGSTW, LGSTU), a publicly-traded special purpose acquisition company, announced today that its shareholders have approved the proposed business combination (the...
New York, NY, Jan. 24, 2024 (GLOBE NEWSWIRE) -- Semper Paratus Acquisition Corporation (“Semper Paratus”) (Nasdaq: LGST, LGSTW), a publicly-traded special purpose acquisition company, today announced that it has filed a supplement (“Prospectus Supplement”) to its defin...